Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF – Get Free Report)’s stock price dropped 6.9% on Monday . The stock traded as low as $18.10 and last traded at $18.10. Approximately 255 shares were traded during mid-day trading, a decline of 77% from the average daily volume of 1,110 shares. The stock had previously closed at $19.45.
Kyowa Kirin Price Performance
The firm’s fifty day moving average is $17.42 and its two-hundred day moving average is $17.24.
Kyowa Kirin Company Profile
Kyowa Kirin Co, Ltd. manufactures and markets pharmaceuticals that focuses on the therapeutic areas of oncology, nephrology, central nervous system, and immunology worldwide. Its products include ABSTRAL, a sublingual formulation of fentanyl used for the management of episodes of breakthrough pain experienced by cancer patients; ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.
Further Reading
- Five stocks we like better than Kyowa Kirin
- What Do S&P 500 Stocks Tell Investors About the Market?
- Best Bear Market Funds: Top 3 Investment Options to Consider
- How to Use the MarketBeat Stock Screener
- Is DraftKings A Good Bet Ahead of Q1 Earnings?
- What Are the U.K. Market Holidays? How to Invest and Trade
- Mid-Cap Stocks to Outperform the Market This Cycle
Receive News & Ratings for Kyowa Kirin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kyowa Kirin and related companies with MarketBeat.com's FREE daily email newsletter.
